Medicine & Life Sciences
Praziquantel
100%
Schistosomiasis
71%
Mass Drug Administration
42%
Schistosomiasis haematobia
36%
Insurance Benefits
33%
Preschool Children
30%
Child
24%
Parasites
23%
Drug Therapy
17%
Population
15%
Pediatrics
15%
Mebendazole
15%
Antibodies
13%
Infections
13%
Epidemiology
12%
Therapeutics
12%
Age Groups
12%
Schistosoma haematobium
11%
Schistosoma
11%
Health Services Needs and Demand
10%
Neglected Diseases
10%
Helminths
9%
Ecology
9%
Antigens
9%
Albuminuria
9%
Africa South of the Sahara
8%
Tablets
8%
Parasitic Diseases
8%
Pharmaceutical Preparations
8%
Public Health
8%
Immune System Diseases
8%
Adaptive Immunity
8%
Proteinuria
7%
Innate Immunity
7%
Morbidity
7%
Ovum
7%
Sweetening Agents
6%
Anthelmintics
6%
Antibody Formation
6%
Vaccines
6%
Immunoglobulin G
5%
Pathology
5%
Agriculture & Biology
Schistosoma
29%
drug therapy
24%
antibodies
16%
praziquantel
9%
antibody formation
6%
Haematobia
5%
antigens
5%